Share this page

On Tuesday, May 5, 2026, from 09:00 AM to 11:30 AM (Taipei Time), the Faculty of Pharmacy, Mahidol University (MUPY), led by Assoc. Prof. Surakit Nathisuwan, Dean, together with the executive team—Assoc. Prof. Dr. Wichit Nosoongnoen, Deputy Dean for Research and Innovation; Assoc. Prof. Dr. Sitaporn Youngkong, Deputy Dean for Global Partnerships and Corporate Communication; Assoc. Prof. Dr. Brompoj Prutthiwanasan, Deputy Dean for Graduate Studies and Information Technology; Asst. Prof. Jennis Meanwatthana, Deputy Dean for the Doctor of Pharmacy Program (International Program); and Dr. Pongpol Thanuphol, Assistant Dean for Corporate Communication—as well as Dr. Amporn Songkasiri, Head of the Division of International and Public Relations, visited the Department of Pharmacy, Taipei Veterans General Hospital (TVGH), Taipei, Republic of China (Taiwan).

On this occasion, the MUPY delegation was welcomed by Prof. Dr. Yung-Yang Lin, MD, Vice Superintendent, Dr. Chian-Ying Chou, Director of Pharmacy, and Dr. Yuh-Lih Chang, Senior Director of Pharmacy. A key highlight of the visit was the signing of a Memorandum of Understanding (MoU) between MUPY and TVGH, marking a significant milestone in strengthening institutional collaboration. The visit also provided a valuable platform for both parties to engage in discussions on advancing cooperation in clinical pharmacy training, student exchange, and academic development. In addition, the delegation toured key research facilities and laboratories at TVGH, gaining insights into the hospital’s advanced pharmaceutical services and research capabilities.

The MoU signing marks a significant step in MUPY’s ongoing efforts to foster international partnerships, promote collaborative research, and expand academic exchange, thereby reinforcing its global role in pharmacy education and healthcare. The initiative also aligns with the Faculty of Pharmacy, Mahidol University’s commitment to the United Nations Sustainable Development Goals (SDGs), particularly SDG 3 (Good Health and Well-being) and SDG 4 (Quality Education), through the promotion of international collaboration, advancement of pharmaceutical research, and enhancement of global academic exchange.